Preserved flow-mediated dilation but delayed time-to-peak diameter in individuals with metabolic syndrome

Clinical Physiology and Functional Imaging

Volumn 34, Issue 4, 2014, Pages 270-276

  Fernandes, Igor A ^a   Sales, Allan R K ^a   Rocha, Natália G ^a   Silva, Bruno M ^b   Vianna, Lauro C ^a   Da Nóbrega, Antonio C L ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Doppler; Endothelial function; Hyperaemia; Shear stress; Vascular reactivity

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;

ANTHROPOMETRY; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK FACTOR; SHEAR RATE; SHEAR STRESS; VASODILATATION; ADOLESCENT; ADULT; ARM; BLOOD ANALYSIS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; DOPPLER FLOWMETRY; ECHOGRAPHY; MECHANICAL STRESS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VIDEORECORDING;

ADOLESCENT; ADULT; ARM; BLOOD CHEMICAL ANALYSIS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PHYSICAL EXAMINATION; RISK FACTORS; STRESS, MECHANICAL; ULTRASONOGRAPHY, DOPPLER; VASODILATION; VIDEO RECORDING;

EID: 84901853545     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/cpf.12092     Document Type: Article

References (27)

1. Aizawa K, Shoemaker JK, Overend TJ, Petrella RJ. Metabolic syndrome, endothelial function and lifestyle modification. Diab Vasc Dis Res (2009); 6: 181-189.
2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation (2009); 120: 1640-1645.
3. Atkinson G, Batterham AM. Allometric scaling of diameter change in the original flow-mediated dilation protocol. Atherosclerosis (2013); 226: 425-427.
4. Atkinson G, Batterham AM, Thijssen DHJ, Green DJ. A new approach to improve the specificity of flow-mediated dilation for indicating endothelial function in cardiovascular research. J Hypertens (2013); 31: 287-291.
5. Balligand JL, Feron O, Dessy C. eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues. Physiol Rev (2009); 89: 481-534.
6. Berry KL, Skyrme-Jones RA, Meredith IT. Occlusion cuff position is an important determinant of the time course and magnitude of human brachial artery flow-mediated dilation. Clin Sci (Lond) (2000); 99: 261-267.
7. Black MA, Cable NT, Thijssen DH, Green DJ. Importance of measuring the time course of flow-mediated dilatation in humans. Hypertension (2008); 51: 203-210.
8. Black MA, Cable NT, Thijssen DH, Green DJ. Impact of age, sex, and exercise on brachial artery flow-mediated dilatation. Am J Physiol Heart Circ Physiol (2009); 297: H1109-H1116.
9. Carson RT, Vignali DA. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods (1999); 227: 41-52.
10. Hamed SA, Hamed EA, Ezz Eldin AM, Mahmoud NM. Vascular risk factors, endothelial function, and carotid thickness in patients with migraine: relationship to atherosclerosis. J Stroke Cerebrovasc Dis (2010); 19: 92-103.
11. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J (2009); 73: 411-418.
12. Irace C, Tschakovsky ME, Carallo C, Cortese C, Gnasso A. Endothelial dysfunction or dysfunctions? Identification of three different FMD responses in males with type 2 diabetes. Atherosclerosis (2008); 200: 439-445.
13. Kizhakekuttu TJ, Gutterman DD, Phillips SA, Jurva JW, Arthur EI, Das E, Widlansky ME. Measuring FMD in the brachial artery: how important is QRS gating? J Appl Physiol (2010); 109: 959-965.
14. Lind L. Endothelium-dependent vasodilation, insulin resistance and the metabolic syndrome in an elderly cohort: the prospective investigation of the vasculature in Uppsala seniors (PIVUS) study. Atherosclerosis (2008); 196: 795-802.
15. Liuni A, Luca MC, Lisi M, Dragoni S, di Stolfo G, Mariani JA, Uxa A, Gori T, Parker JD. Observations of time-based measures of flow-mediated dilation of forearm conduit arteries: implications for the accurate assessment of endothelial function. Am J Physiol Heart Circ Physiol (2010); 299: H939-H945.
16. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care (2005); 28: 385-390.
17. Padilla J, Johnson BD, Newcomer SC, Wilhite DP, Mickleborough TD, Fly AD, Mather KJ, Wallace JP. Adjusting flow-mediated dilation for shear stress stimulus allows demonstration of endothelial dysfunction in a population with moderate cardiovascular risk. J Vasc Res (2009); 46: 592-600.
18. Parker BA, Tschakovsky ME, Augeri AL, Polk DM, Thompson PD, Kiernan FJ. Heterogenous vasodilator pathways underlie flow-mediated dilation in men and women. Am J Physiol Heart Circ Physiol (2011); 301: H1118-H1126.
19. Pyke KE, Tschakovsky ME. Peak vs. total reactive hyperemia: which determines the magnitude of flow-mediated dilation? J Appl Physiol (2007); 102: 1510-1519.
20. Skogstrand K, Thorsen P, Norgaard-Pedersen B, Schendel DE, Sorensen LC, Hougaard DM. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem (2005); 51: 1854-1866.
21. Suzuki T, Hirata K, Elkind MS, Jin Z, Rundek T, Miyake Y, Boden-Albala B, Di Tullio MR, Sacco R, Homma S. Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS). Am Heart J (2008); 156: 405-410.
22. Thijssen DH, Dawson EA, Black MA, Hopman MT, Cable NT, Green DJ. Heterogeneity in conduit artery function in humans: impact of arterial size. Am J Physiol Heart Circ Physiol (2008); 295: H1927-H1934.
23. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol (2011); 300: H2-H12.
24. Title LM, Lonn E, Charbonneau F, Fung M, Mather KJ, Verma S, Anderson TJ. Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome. Vasc Med (2008); 13: 263-270.
25. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the cardiovascular health study. Circulation (2007); 115: 2390-2397.
26. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation (2009); 120: 502-509.
27. Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol (2008); 103: 398-406.